2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
Product Name: 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
CAS No.: 32384-65-9
Molecular Formula: C18H42O6Si4
Molecular Weight: 466.86
Physical Properties:
- Appearance: Colorless to pale yellow oily liquid
- Density: ~0.97 g/cm³
- Boiling Point: 417°C
- Flash Point: 171°C
- Specific Optical Rotation: 46.8°
Product Description:
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone is an organosilicon compound serving primarily as a synthetic intermediate for Type 2 diabetes medications such as dapagliflozin and canagliflozin.
Key Features:
- All four hydroxyl groups protected by trimethylsilyl groups
- Used for modification and transformation of glycosyl structures during drug synthesis
- Purity typically ≥ 97%
- Water content controlled below 0.03%
Applications:
- Pharmaceutical intermediate for diabetes medications
- Dapagliflozin synthesis
- Canagliflozin synthesis
- Glycosyl structure modification
- Drug synthesis research
Product Category: Pharmaceutical Intermediates / Organosilicon Compounds / Diabetes Drug Intermediates
Keywords: 32384-65-9, 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone, Dapagliflozin intermediate, Canagliflozin intermediate
Note: For research and development purposes only.
Product Classification:
- Pharmaceutical Intermediates
- Organosilicon Compounds
- Diabetes Drug Intermediates
- Building Blocks
CAS No.: 32384-65-9
Molecular Formula: C18H42O6Si4
Molecular Weight: 466.86
Physical Properties:
- Appearance: Colorless to pale yellow oily liquid
- Density: ~0.97 g/cm³
- Boiling Point: 417°C
- Flash Point: 171°C
- Specific Optical Rotation: 46.8°
Product Description:
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone is an organosilicon compound serving primarily as a synthetic intermediate for Type 2 diabetes medications such as dapagliflozin and canagliflozin.
Key Features:
- All four hydroxyl groups protected by trimethylsilyl groups
- Used for modification and transformation of glycosyl structures during drug synthesis
- Purity typically ≥ 97%
- Water content controlled below 0.03%
Applications:
- Pharmaceutical intermediate for diabetes medications
- Dapagliflozin synthesis
- Canagliflozin synthesis
- Glycosyl structure modification
- Drug synthesis research
Product Category: Pharmaceutical Intermediates / Organosilicon Compounds / Diabetes Drug Intermediates
Keywords: 32384-65-9, 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone, Dapagliflozin intermediate, Canagliflozin intermediate
Note: For research and development purposes only.
Product Classification:
- Pharmaceutical Intermediates
- Organosilicon Compounds
- Diabetes Drug Intermediates
- Building Blocks
| Short Description | Organosilicon intermediate for diabetes drug synthesis |
|---|---|
| MOQ | 1 Piece |
| Contact supplier for shipping and payment information. |
📦 Shipping costs are estimated and will be confirmed with the supplier.
💳 Payment terms may vary based on order quantity and buyer history.
More Products from Shenzhen Polymeri Biochemical Technology Co., Ltd.
View All Products →Send Inquiry for 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
Fill out the form below and the supplier will respond to you shortly.